ASH 2022 Conference Coverage
G

ASH 2022 Myeloma XI Trial: Defining the Optimal Duration of Lenalidomide Maintenance After ASCT

By ASH 2022 Conference Coverage FEATURING Gareth Morgan
December 16, 2022
0 Comments
Login to view comments. Click here to Login

Featured Video

31:59
TLS Education

Comparison of Real-World Activity of Post-Hyperuricemia Treatment Op…

Feat. M. Cairo

Featured Video

19:14
Bristol Myers Squibb Hematology

Study Results of a Treatment Option for AML Patients

Feat. J. Mccloskey, T. Leblanc

Related Content

AUTOPLAY
26:57
Saad Usmani

Immune Approaches and Targeted Therapies for Myeloma: The Future

13:19
Xth Eurasian Hematology-Oncology Congress

Moscow National Hematological Centre Experience on the Role and Plac…

Feat. L. Mendeleeva, M. Solovev
20:32
KU ASH 2019 Review: Current Updates in Hematologic Diseases

ASH 2019 Update on the Bone Marrow Procedures with a Dry Tap: KUH Dr…

Feat. J. Woodroof
18:27
Rush University Medical Center's Biennial Cardio-Oncology Symposium 2021

Cardiovascular Perspectives on Stem Cell Transplant and CAR T Cell T…

Feat. V. Zaha
13:40
Xth Eurasian Hematology-Oncology Congress

Bone Marrow Allogenic Transplantation in Relapsed/ Refractory Hem Ma…

Feat. I. Moiseev
11:33
SOHO Italy 1st School of Multiple Myeloma

Allograft in MM: Is There a Role for AlloHSCT & Will Newer Drug …

Feat. F. Vozella
18:23
SOHO Italy 1st School of Multiple Myeloma

Bone Marrow Fibroblasts in MM Progression and Tumor Cells Reprogramm…

Feat. I. Saltarella
22:57
Xth Eurasian Hematology-Oncology Congress

Importance of MRD in Multiple Myeloma: Can MRD Guide Therapy in Newl…

Feat. E. Terpos
11:56
UNMC 2020 Lymphoma Study Group & Hematology Highlights: A Post ASH Review

ASH 2019 Myeloma Highlights: Genetic Engineering of T-cells, Dara-VM…

Feat. A. Rosko
15:23
Society of Hematologic Oncology Eighth Annual Meeting (SOHO 2020)

2020 SOHO Highlights on Frontline MM for Older Adults: Does Biologic…

Feat. B. Lipe
03:34
Krina Patel

The Future in Multiple Myeloma: BiTE, CAR T, PI, & IMID

21:58
Penn Medicine's 2020 Updates in Care of the Hematologic Malignancies Patient

Treatment of 57 y/o Women with Myeloma R-ISS Stage 1, Anemia and Lyt…

Feat. A. Cohen, D. Vogl, A. Garfall
14:12
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Myeloma Bone Disease and Management: Optimal Imaging Supports Clinic…

Feat. M. Drake
15:54
XIth Eurasian Hematology-Oncology Congress - EHOC 2020

MRD in Newly Diagnosed MM: MRI vs. PET/CT, RVD+/-ASCT, Dara+Len to R…

Feat. E. Terpos
15:10
Krina Patel

Developing CAR T-cells in Multiple Myeloma

08:48
SOHO 4th Italian Conference

SOHO Italy 2022: Therapy-Related Myeloid Neoplasm After Multiple Mye…

Feat. L. Cicconi
09:50
Nina Shah

Maximizing the Initial Gains in Myeloma Therapy: Consolidation and M…

13:27
Shaji Kumar

Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma

15:09
2nd SOHO Italian Conference

How I Treat Unfit/Frail MM Patients: Is Frailty Measurable and Do No…

Feat. D. Derudas
13:22
SOHO 3rd Italian Conference

SOHO Italy 2021 on the Importance of Imaging in Novel Agents' E…

Feat. E. Zamagni